BASF Sales, Earnings Miss Forecasts on Lower Margins, Write-Downs — Update
By Andrea Figueras
BASF said sales and earnings last year missed both the company's guidance and consensus expectations, dragged by write-downs and sales of lower-margin products.
Reporting preliminary figures, the German chemicals giant said Friday that it expects to book a 1.1 billion-euro ($1.20 billion) hit mainly related to noncash write-downs of its surface technologies, agricultural and materials segments.
Sales were EUR68.90 billion, according to the preliminary figures, down from EUR87.33 billion in 2022. The company had previously guided for sales of between EUR73 billion and EUR76 billion, while analysts had forecast EUR70.58 billion.
Earnings before interest and taxes before special items fell to EUR3.81 billion from EUR6.88 billion, the company said. This compared with its forecast range of EUR4.0 billion and EUR4.4 billion and analysts' consensus estimate of EUR3.93 billion.
BASF said it swung to a net profit of EUR225 million from a loss of EUR627 million a year earlier, when it was hit by impairments on Russia-related assets of its oil-and-gas business Wintershall Dea, but still missed analysts' expectations of EUR2.25 billion.
The company will publish its full 2023 report on Feb. 23.
Write to Andrea Figueras at andrea.figueras@wsj.com
(END) Dow Jones Newswires
January 19, 2024 02:17 ET (07:17 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom